Drug Trial Radar · NCT01281202
Vigabatrin for the Treatment of Cocaine Dependency
Last checked: Nov 19, 2026Latest source record: May 18, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
207
Actual
Start
Jan 2011
Primary completion
Oct 2012
Study completion Dec 2012
Sponsor
- Lead sponsor
- Catalyst Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- National Institute on Drug Abuse (NIDA); VA Office of Research and Development
- First posted
- Jan 21, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this 26-28 week study is to demonstrate that the rate of cocaine dependent subjects treated with CPP-109 vigabatrin in addition to counseling, who completely stop use of cocaine in the last 2 weeks of the study's Treatment Phase (Weeks 8 and 9) will be higher than seen in subjects treated with placebo in addition to counseling.
Conditions
- Cocaine Addiction
- Cocaine Dependence
Interventions
VigabatrinDrug
Tablets
Matching PlaceboDrug
Tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- AbstinenceTime frame: Weeks 8-9
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Matrix Institute on Addictions
Los Angeles, California
Friends Research Institute
Torrance, California
VA Medical Center
Denver, Colorado
University of Miami School of Medicine
Miami, Florida
NeuroPsychiatric Research & Practice Assoc., Ltd.
Oak Brook, Illinois
Mountain Manor Treatment Center @ Baltimore
Baltimore, Maryland
Boston University School of Medicine
Boston, Massachusetts
Pacific Institute for Research and Evaluation
Albuquerque, New Mexico
Western Psychiatric Inst. and Clinic
Pittsburgh, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Pillar Clinical Research, LLC
Dallas, Texas
University of Texas Health Science Center at Houston
Houston, Texas
George E Wahlen VA Medical Center
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.